Explore more publications!
Latin America Health Times
Submit Press Release

Latin America Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 26, 2025

Un gala du siècle pour célébrer 100 ans d’espoir, de guérison et d’innovation aux Hôpitaux Shriners pour enfants Canada
September 26, 2025

Un gala du siècle pour célébrer 100 ans d’espoir, de guérison et d’innovation aux Hôpitaux Shriners pour enfants Canada

Indeterminate GlobeNewswire
Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.
September 26, 2025

Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.

Indeterminate GlobeNewswire
Intelligent Bio Solutions Advances Preparations and Provides Updated Timeline for Anticipated FDA 510(k) Submission and Clearance
September 26, 2025

Intelligent Bio Solutions Advances Preparations and Provides Updated Timeline for Anticipated FDA 510(k) Submission and Clearance

Indeterminate GlobeNewswire
Amneal Announces BLA Submission of Biosimilar Candidate to XOLAIR® (omalizumab)
September 26, 2025

Amneal Announces BLA Submission of Biosimilar Candidate to XOLAIR® (omalizumab)

Indeterminate GlobeNewswire
BioVie to Host Live Investor Webinar and Q&A on Oct. 8
September 26, 2025

BioVie to Host Live Investor Webinar and Q&A on Oct. 8

Indeterminate GlobeNewswire
Aveanna to Participate at the Deutsche Bank Annual Leveraged Finance Conference
September 26, 2025

Aveanna to Participate at the Deutsche Bank Annual Leveraged Finance Conference

Indeterminate GlobeNewswire
Fractyl Health Announces Pricing of $60 Million Underwritten Offering of Common Stock
September 26, 2025

Fractyl Health Announces Pricing of $60 Million Underwritten Offering of Common Stock

Indeterminate GlobeNewswire
Harrow to Acquire Melt Pharmaceuticals
September 26, 2025

Harrow to Acquire Melt Pharmaceuticals

Indeterminate GlobeNewswire
Fractyl Health Announces Groundbreaking Data from REMAIN-1 Midpoint Cohort Showing Revita® Maintained Weight Loss After GLP-1 Discontinuation
September 26, 2025

Fractyl Health Announces Groundbreaking Data from REMAIN-1 Midpoint Cohort Showing Revita® Maintained Weight Loss After GLP-1 Discontinuation

Indeterminate GlobeNewswire
RadNet, Inc. to Present at the Jefferies Healthcare Services Conference on September 29, 2025
September 26, 2025

RadNet, Inc. to Present at the Jefferies Healthcare Services Conference on September 29, 2025

Indeterminate GlobeNewswire
Dogecoin Cash, Inc. (OTCQB: DOGP) Subsidiary PrestoDoctor Expands Telehealth Cannabis Evaluations to Connecticut, Now Operating in 19 States Nationwide
September 26, 2025

Dogecoin Cash, Inc. (OTCQB: DOGP) Subsidiary PrestoDoctor Expands Telehealth Cannabis Evaluations to Connecticut, Now Operating in 19 States Nationwide

Indeterminate GlobeNewswire
BioPorto Sponsors Conferences on Pediatric Critical Care with New NGAL Scientific Data Presented
September 26, 2025

BioPorto Sponsors Conferences on Pediatric Critical Care with New NGAL Scientific Data Presented

Indeterminate GlobeNewswire
Fangzhou’s ‘XingShi’ LLM Featured by Nature News and Xinhua, Showcasing AI Innovation in Chronic Disease Care
September 26, 2025

Fangzhou’s ‘XingShi’ LLM Featured by Nature News and Xinhua, Showcasing AI Innovation in Chronic Disease Care

Indeterminate GlobeNewswire
Mesoblast Cell Therapy Products are Designated U.S. Origin and Not Subject to Tariffs
September 26, 2025

Mesoblast Cell Therapy Products are Designated U.S. Origin and Not Subject to Tariffs

Indeterminate GlobeNewswire
uniQure Announces Pricing of Upsized $300 Million Public Offering
September 26, 2025

uniQure Announces Pricing of Upsized $300 Million Public Offering

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions